Pharma Journalist -

In December, 120 senior figures from industry and academia will be uniting at the foremost gene editing drug development meeting, the 5th Genome Editing Therapeutics Summit (formerly…
Read More...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has received conditional approval in China as a monotherapy for the treatment of adult patients with unresectable,…
Read More...

UCB, a global biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has approved a 2 mL pre-filled syringe and pre-filled autoinjector, each containing…
Read More...

Roche announced that the United States Food and Drug Administration (FDA) approved Itovebi (inavolisib), in combination with palbociclib (Ibrance) and fulvestrant, for the treatment of…
Read More...

Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal to develop a first-in-class cyclin inhibitor that…
Read More...

Arda Therapeutics, a pioneer in targeted cell depletion therapies for chronic diseases, announced the successful completion of a $43 million Series A financing round. The round was led…
Read More...

Biogen announced that felzartamab, an investigational anti-CD38 monoclonal antibody, has received Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug Administration (FDA)…
Read More...

insitro, a machine learning-enabled drug discovery and development company, announced the execution of three strategic agreements with Eli Lilly and Company (Lilly) focused on advancing…
Read More...

Teva Pharmaceutical Industries Ltd. announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted, and the European Medicines Agency (EMA) has validated,…
Read More...

Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for survodutide (BI 456906), a dual glucagon/GLP-1 receptor…
Read More...